Insider Stock Trading History of Ajer Jeffrey Robert


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ajer Jeffrey Robert since year 2005. The trader's CIK number is 1557533. At the time of this reporting, Ajer Jeffrey Robert is the EVP, Chief Commercial Officer of Biomarin Pharmaceutical Inc . (stock ticker symbol BMRN). See this page for all insider trading activities at Biomarin Pharmaceutical Inc .


Stock purchases, sales, and option exercises reported by insider Ajer Jeffrey Robert since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-04-02 BMRN Biomarin Pharmaceutical Inc Sale 2,119 80.12 169,774
2018-03-29 BMRN Biomarin Pharmaceutical Inc Sale 1,537 79.69 122,483
2018-03-21 BMRN Biomarin Pharmaceutical Inc Sale 4,368 83.90 366,475
2018-03-09 BMRN Biomarin Pharmaceutical Inc Sale 2,972 82.39 244,863
2017-09-22 BMRN Biomarin Pharmaceutical Inc Sale 3,521 95.00 334,495
2017-09-22 BMRN Biomarin Pharmaceutical Inc Option Ex 3,521 37.46 131,896
2017-06-07 BMRN Biomarin Pharmaceutical Inc Sale 1,004 89.61 89,968
2017-05-05 BMRN Biomarin Pharmaceutical Inc Option Ex 4,486 33.41 149,877
2017-05-05 BMRN Biomarin Pharmaceutical Inc Sale 4,486 99.00 444,114
2017-05-02 BMRN Biomarin Pharmaceutical Inc Sale 302 96.74 29,215
2017-03-29 BMRN Biomarin Pharmaceutical Inc Sale 3,890 89.15 346,793
2017-03-07 BMRN Biomarin Pharmaceutical Inc Sale 5,000 90.56 452,800
2016-09-27 BMRN Biomarin Pharmaceutical Inc Sale 18,467 95.61 1,765,648
2016-03-04 BMRN Biomarin Pharmaceutical Inc Sale 1,255 88.42 110,970
2015-11-02 BMRN Biomarin Pharmaceutical Inc Sale 26 117.56 3,056
2015-07-20 BMRN Biomarin Pharmaceutical Inc Option Ex 3,000 63.10 189,300
2015-07-20 BMRN Biomarin Pharmaceutical Inc Sale 3,000 150.00 450,000
2015-06-04 BMRN Biomarin Pharmaceutical Inc Sale 1,362 122.35 166,646
2015-06-01 BMRN Biomarin Pharmaceutical Inc Sale 377 123.76 46,656
2015-05-26 BMRN Biomarin Pharmaceutical Inc Sale 1,625 126.55 205,647
2015-05-06 BMRN Biomarin Pharmaceutical Inc Option Ex 33,631 30.43 1,023,290
2015-05-06 BMRN Biomarin Pharmaceutical Inc Sale 34,019 119.17 4,053,942
2014-12-03 BMRN Biomarin Pharmaceutical Inc Option Ex 12,000 38.59 463,080
2014-12-03 BMRN Biomarin Pharmaceutical Inc Sale 12,000 91.01 1,092,156
2014-11-03 BMRN Biomarin Pharmaceutical Inc Sale 47 83.54 3,926
2014-06-02 BMRN Biomarin Pharmaceutical Inc Sale 377 57.84 21,803
2014-05-16 BMRN Biomarin Pharmaceutical Inc Sale 1,004 56.91 57,135
2014-05-13 BMRN Biomarin Pharmaceutical Inc Sale 478 58.18 27,809
2014-05-09 BMRN Biomarin Pharmaceutical Inc Sale 621 57.96 35,991
2014-05-01 BMRN Biomarin Pharmaceutical Inc Sale 666 59.55 39,660
2014-03-06 BMRN Biomarin Pharmaceutical Inc Option Ex 17,370 24.87 431,991
2014-03-06 BMRN Biomarin Pharmaceutical Inc Sale 17,370 78.63 1,365,837
2013-12-09 BMRN Biomarin Pharmaceutical Inc Option Ex 13,026 17.92 233,425
2013-12-09 BMRN Biomarin Pharmaceutical Inc Sale 13,026 69.55 906,010
2013-11-01 BMRN Biomarin Pharmaceutical Inc Sale 99 63.16 6,252
2013-06-03 BMRN Biomarin Pharmaceutical Inc Sale 493 58.34 28,763
2013-05-13 BMRN Biomarin Pharmaceutical Inc Sale 1,248 69.25 86,430
2013-05-09 BMRN Biomarin Pharmaceutical Inc Sale 811 66.00 53,528
2013-05-01 BMRN Biomarin Pharmaceutical Inc Sale 797 64.52 51,420
2013-04-19 BMRN Biomarin Pharmaceutical Inc Option Ex 5,000 21.51 107,550
2013-04-19 BMRN Biomarin Pharmaceutical Inc Sale 5,000 65.00 325,000
2013-03-04 BMRN Biomarin Pharmaceutical Inc Sale 4,000 60.00 240,000
2013-03-04 BMRN Biomarin Pharmaceutical Inc Option Ex 4,000 21.51 86,040
2013-01-22 BMRN Biomarin Pharmaceutical Inc Option Ex 3,000 21.51 64,530
2013-01-22 BMRN Biomarin Pharmaceutical Inc Sale 3,000 55.00 165,000
2012-11-28 BMRN Biomarin Pharmaceutical Inc Sale 5,916 48.31 285,819
2012-11-28 BMRN Biomarin Pharmaceutical Inc Option Ex 5,916 17.92 106,014
2012-11-12 BMRN Biomarin Pharmaceutical Inc Sale 265 48.11 12,750

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ajer Jeffrey Robert (EVP, Chief Commercial Officer of Biomarin Pharmaceutical Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.